N-[4-(acetylsulfamoyl)phenyl]-6-(4-fluorophenyl)-3-methylimidazo[2,1-b][1,3]thiazole-2-carboxamide
C21H17FN4O4S2 — CID 43953478
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[4-(acetylsulfamoyl)phenyl]-6-(4-fluorophenyl)-3-methylimidazo[2,1-b][1,3]thiazole-2-carboxamide
N-[4-(acetylsulfamoyl)phenyl]-6-(4-fluorophenyl)-3-methylimidazo[2,1-b][1,3]thiazole-2-carboxamide (PubChem CID 43953478) has the molecular formula C21H17FN4O4S2 and a molecular weight of 472.52 g/mol. Its IUPAC name is N-[4-(acetylsulfamoyl)phenyl]-6-(4-fluorophenyl)-3-methylimidazo[2,1-b][1,3]thiazole-2-carboxamide.
Molecular Properties
| Compound Name | N-[4-(acetylsulfamoyl)phenyl]-6-(4-fluorophenyl)-3-methylimidazo[2,1-b][1,3]thiazole-2-carboxamide |
|---|---|
| PubChem CID | 43953478 |
| Molecular Formula | C21H17FN4O4S2 |
| Molecular Weight | 472.52 g/mol |
| Exact Mass | 472.07 |
| IUPAC Name | N-[4-(acetylsulfamoyl)phenyl]-6-(4-fluorophenyl)-3-methylimidazo[2,1-b][1,3]thiazole-2-carboxamide |
| SMILES | CC(=O)NS(=O)(=O)c1ccc(NC(=O)c2sc3nc(-c4ccc(F)cc4)cn3c2C)cc1 |
| InChI | InChI=1S/C21H17FN4O4S2/c1-12-19(31-21-24-18(11-26(12)21)14-3-5-15(22)6-4-14)20(28)23-16-7-9-17(10-8-16)32(29,30)25-13(2)27/h3-11H,1-2H3,(H,23,28)(H,25,27) |
| InChIKey | GIHNICQOBSNCHH-UHFFFAOYSA-N |
| XLogP | 3.59 |
| TPSA | 109.64 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 32 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 472.52 |
| LogP ≤ 5 | 3.59 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 43953478 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.